Capricor Therapeutics (NASDAQ:CAPR) Price Target Raised to $30.00 at Cantor Fitzgerald
Capricor Therapeutics (NASDAQ:CAPR – Free Report) had its price target raised by Cantor Fitzgerald from $25.00 to $30.00 in a research report released on Thursday morning,Benzinga reports. They currently have an overweight rating on the biotechnology company’s stock. Other equities research analysts have also recently issued reports about the stock. HC Wainwright reiterated a “buy” […]
More Stories
MultiMetaVerse Holdings Limited (NASDAQ:MMV) Short Interest Down 18.3% in October
MultiMetaVerse Holdings Limited (NASDAQ:MMV – Get Free Report) was the recipient of a large decrease in short interest during the...
Short Interest in Gentherm Incorporated (NASDAQ:THRM) Decreases By 18.7%
Gentherm Incorporated (NASDAQ:THRM – Get Free Report) was the target of a significant decline in short interest during the month...
Zillow Group, Inc. (NASDAQ:ZG) General Counsel Sells $134,813.38 in Stock
Zillow Group, Inc. (NASDAQ:ZG – Get Free Report) General Counsel Bradley D. Owens sold 1,846 shares of the company’s stock...
Short Interest in TruGolf Holdings, Inc. (NASDAQ:TRUG) Drops By 19.0%
TruGolf Holdings, Inc. (NASDAQ:TRUG – Get Free Report) was the recipient of a large drop in short interest in October....
Aspira Women’s Health Inc. (NASDAQ:AWH) Short Interest Update
Aspira Women’s Health Inc. (NASDAQ:AWH – Get Free Report) was the target of a significant growth in short interest in...
Beneficient (NASDAQ:BENFW) Short Interest Up 23.3% in October
Beneficient (NASDAQ:BENFW – Get Free Report) was the recipient of a large growth in short interest during the month of...